US approves new drug for prevention of migraines

Migraine sufferers on Thursday got some relief from US regulators who approved the first of a new class of drugs for migraine prevention. The United States Food and Drug Administration said it endorsed Aimovig for prevention of migraine in adults, through monthly self-injections. Aimovig is the first in a new class of drugs that work by blocking the activity of […]
Continue reading »